US10279000B1 – May 7, 2019 – Method for treating cannabis induced anxiety

Please complete the required fields.




Inventors :

Mark Hetherington; Jason Green

Owner :

Canopy Growth Corporation

Application Number :

US15996034

Document Number :

US10279000B1

Priority Date :

June 1, 2018

Filing Date :

June 1, 2018

Date of Grant/ Publication :

May 7, 2019

Class :

; A61K36 / 00; A61K36 / 185; A61K47 / 22; A61P25 / 22; A61K45 / 06; A61K31 / 19; A61K31 / 352; A61K31 / 4453; A61K31 / 015; A61K31 / 05

Abstract

Compositions and methods for the prevention and treatment of anxiety conditions associated with the use of cannabis are disclosed herein. The medicinal compositions include cannabidiol or cannabidiolic acid and one or more of the following compounds: bergamottin or dihydroxybergamottin, phloretin or a phloretin glycoside, piperine, apigenin or an apigenin glycoside and ursolic acid.

Claim(s)

1. A method for treating post traumatic stress disorder associated with the use of cannabis in a human in need thereof consisting essentially of administering to said human in need thereof a pure cannabidiol, a valeriana extract and at least one of the following chemical compounds: (a) bergamottin or dihydroxybergamottin; (b) phloretin or a phloretin glycoside; (c) piperine; (d) apigenin or an apigenin glycoside; and (e) ursolic acid, wherein the pure cannabidiol, a valeriana extract and at least one of the following chemical compounds: (a) bergamottin or dihydroxybergamottin; (b) phloretin or a phloretin glycoside; (c) piperine; (d) apigenin or an apigenin glycoside; and (e) ursolic acid, are administered prior to or following the use of the cannabis.

Summary

No Comments

Leave a comment

Sorry, you must be logged in to post a comment. Login